Titan Biotech Limited is set to hold a Board of Directors meeting on September 3, 2026, to consider a proposal for issuing bonus shares to eligible shareholders. This decision follows the company’s strong financial performance in the first quarter of FY27, where it reported a consolidated net profit of ₹10.86 crore—a 58.31% year-on-year increase—and sales growth of 27.25% to ₹59.17 crore. The board will also finalize preparations for the upcoming Annual General Meeting. The planned bonus issue aims to reward shareholders and enhance stock liquidity, complementing a recent stock split executed earlier this year. Despite the positive outlook, investors should be mindful of potential equity dilution and margin volatility that may arise from commodity price fluctuations.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.sahi.com/news/titan-biotech-board-to-consider-bonus-share-issue-on-september-3-1697-PE1_COR
